NasdaqCM:WORX

Stock Analysis Report

Executive Summary

SCWorx Corp. provides software solutions for the management of health care providers’ foundational business applications.

Snowflake

Fundamentals

Imperfect balance sheet and overvalued.

Risks

  • SCWorx has significant price volatility in the past 3 months.
  • SCWorx is not covered by any analysts.

Share Price & News

How has SCWorx's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

18.0%

NasdaqCM:WORX

2.1%

US Healthcare Services

1.1%

US Market


1 Year Return

n/a

NasdaqCM:WORX

7.7%

US Healthcare Services

2.1%

US Market

No trading data on WORX.

No trading data on WORX.


Share holder returns

WORXIndustryMarket
7 Day18.0%2.1%1.1%
30 Day104.4%-4.7%3.7%
90 Day-19.6%-4.6%2.3%
1 Yearn/a7.7%7.7%4.4%2.1%
3 Yearn/a51.1%50.8%47.0%37.4%
5 Yearn/a49.2%48.3%61.6%43.8%

Price Volatility Vs. Market

How volatile is SCWorx's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is SCWorx undervalued based on future cash flows and its price relative to the stock market?

3.36x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for SCWorx to establish if it is available at moderate discount.

Unable to calculate intrinsic value for SCWorx to establish if it is available at substantial discount.


Price Based on Earnings

SCWorx is loss making, we can't compare its value to the US Healthcare Services industry average.

SCWorx is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for SCWorx, we can't assess if its growth is good value.


Price Based on Value of Assets

SCWorx is good value based on assets compared to the US Healthcare Services industry average.


Next Steps

Future Growth

How is SCWorx expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

27.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SCWorx has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has SCWorx performed over the past 5 years?

-10247.1%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

SCWorx does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.

Unable to compare SCWorx's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare SCWorx's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if SCWorx has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if SCWorx has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if SCWorx improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is SCWorx's financial position?


Financial Position Analysis

SCWorx's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

SCWorx has no long term commitments.


Debt to Equity History and Analysis

SCWorx's level of debt (2.3%) compared to net worth is satisfactory (less than 40%).

Unable to establish if SCWorx's debt level has increased without past 5-year debt data.


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 13.7x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

SCWorx has less than a year of cash runway based on current free cash flow.

SCWorx has less than a year of cash runway if free cash flow continues to grow at historical rates of 104.8% each year.


Next Steps

Dividend

What is SCWorx's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate SCWorx's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate SCWorx's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as SCWorx has not reported any payouts.

Unable to verify if SCWorx's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as SCWorx has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of SCWorx's salary, the management and board of directors tenure and is there insider trading?

0.6yrs

Average management tenure


CEO

Marc Schessel (56yo)

7.7yrs

Tenure

US$100,000

Compensation

Mr. Marc S. Schessel is SCWorx Corp.'s Founder, Chairman and Chief Executive Officer. He founded SCWorx’s predecessor (Primrose LLC) in 2012 and has been Chairman and CEO of SCWorx since then. Commencing h ...


CEO Compensation Analysis

Insufficient data for Marc to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.

Insufficient data for Marc to compare compensation growth.


Management Age and Tenure

0.6yrs

Average Tenure

52yo

Average Age

The average tenure for the SCWorx management team is less than 2 years, this suggests a new team.


Board Age and Tenure

0.6yrs

Average Tenure

57yo

Average Age

The average tenure for the SCWorx board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Tad Schweikert (52yo)

    Chief Operating Officer

    • Tenure: 0.3yrs
  • John Price (48yo)

    CFO, Treasurer

    • Tenure: 0.6yrs
  • Marc Schessel (56yo)

    Chairman & CEO

    • Tenure: 7.7yrs
    • Compensation: US$100.00k

Board Members

  • Frank Knuettel (53yo)

    Director

    • Tenure: 0.6yrs
  • Bob Christie (65yo)

    Director

    • Tenure: 0.6yrs
  • Charles Miller (58yo)

    Director

    • Tenure: 0.6yrs
  • Ira Ritter (70yo)

    Director

    • Tenure: 0.6yrs
  • John Price (48yo)

    CFO, Treasurer

    • Tenure: 0.6yrs
  • Marc Schessel (56yo)

    Chairman & CEO

    • Tenure: 7.7yrs
    • Compensation: US$100.00k

Company Information

SCWorx Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: SCWorx Corp.
  • Ticker: WORX
  • Exchange: NasdaqCM
  • Founded:
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$27.588m
  • Shares outstanding: 6.58m
  • Website: https://www.scworx.com

Number of Employees


Location

  • SCWorx Corp.
  • 590 Madison Avenue
  • 21st Floor
  • New York
  • New York
  • 10022
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
WORXNasdaqCM (Nasdaq Capital Market)YesCommon SharesUSUSDFeb 2019

Biography

SCWorx Corp. provides software solutions for the management of health care providers’ foundational business applications. The company provides services related to repair, normalization, and interoperabilit ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/17 00:53
End of Day Share Price2019/09/16 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.